Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4639 reports available
All reports
Page 71 of 194
On The Road With Goldman Sachs European Edition
Goldman Sachs · Jun 11, 2026
Super Retail Group Strategy Day Key Takeaways
Goldman Sachs · Jun 11, 2026
Re-pricing the US Renewable Industry
Goldman Sachs · Jun 11, 2026
Consumer Cash Pile
J.P. Morgan · Jun 11, 2026
ECB Review: One Hike, No Path
UBS · Jun 11, 2026
Fed Communication And Rates Volatility
Goldman Sachs · Jun 10, 2026
EU Consumer Sector Specialist Commentary
J.P. Morgan · Jun 10, 2026
Asia Pacific Textile Apparel and Footwear Monthly Tracker
Goldman Sachs · Jun 10, 2026
The ECB Is Right To Hike
Crédit Agricole Corporate and Investment Bank · Jun 10, 2026
G10 FX Daily Report
JPMorganChase · Jun 10, 2026
China Healthcare Hospital Equipment Bidding Update
Goldman Sachs · Jun 10, 2026
New Amsterdam Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
Boj Preview: A High Bar For Hawkishness
J.P. Morgan · Jun 10, 2026
Americas Morning Research Summary
Barclays · Jun 10, 2026
The Point For Europe
Citi · Jun 10, 2026
The Point For Japan
Citi · Jun 10, 2026
Americas FX Morning Bullets
HSBC · Jun 10, 2026
Europe Technology Hardware Update
Goldman Sachs · Jun 10, 2026
European Morning Research Summary
Barclays · Jun 10, 2026
New Zealand Agri Focus
ANZ · Jun 10, 2026
Novo Nordisk Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · Jun 10, 2026
The Point for Asia Pacific
Citi · Jun 10, 2026
Moderna Inc. Key Takeaways 47th Annual Global Healthcare Conference
Goldman Sachs · Jun 10, 2026